Figure 2 Figure 3 5 Effects of GLP-1 receptor agonists on biomarkers of inflammation In a systematic review and meta-analysis conducted by Bray et al., data from 40 randomized controlled trials were analyzed to examine the effects of GLP-1RAs on biomarkers of inflammation and oxidative stress in patients with type 2 diabetes
data comparing semaglutide sodium or acetate to semaglutide base in humans
One promising tool in combating inflammation is Semaglutidea medication originally developed to manage blood sugar in type 2 diabetes, now widely recognized for its benefits in weight loss and metabolic health
There were other effects on reducing some symptoms of type 2 diabetes, including fatigue and insomnia, after 6 months of treatment
Sun J, Zeng Q, Wu Z, Huang L, Sun T, Ling C, et al